Senior insider sale
Chief Executive Officer at CORBUS PHARMACEUTICALS HOLDINGS, INC. — senior position signals high conviction
$812.6K
20K shares
What this filing means
COHEN YUVAL plans to sell 20K shares of CORBUS PHARMACEUTICALS HOLDINGS, INC. valued at approximately $812.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/13/2026ACC: 0001972481-26-000054
DirectorOfficer· Chief Executive Officer
Since Jan 2019
20K
Shares to sell
$812.6K
Approx. market value
20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
2/13/2026
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2026 | Restricted Stock Units Equity Compensation | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
20K
Market value
$812.6K
2/13/2026
Total
Units
20K
Value
$812.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/13/2026 | 20K | $812.6K | Nasdaq | Planned |
| Total | 20K | $812.6K | ||